IR@PKUHSC  > 北京大学第二临床医学院
学科主题临床医学
ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY
Jiang, Q.1; Wang, H. B.2; Mo, X. D.1; Yu, L.1; Huang, X. J.1
刊名HAEMATOLOGICA
2015-06-01
suppl.1页:698-698
收录类别SCI ; ISTP
文章类型Meeting Abstract
WOS标题词Science & Technology
类目[WOS]Hematology
研究领域[WOS]Hematology
语种英语
WOS记录号WOS:000361204904302
Citation statistics
文献类型期刊论文
条目标识符http://ir.bjmu.edu.cn/handle/400002259/65767
Collection北京大学第二临床医学院
作者单位1.Peking Univ, Peoples Hosp, Beijing 100871, Peoples R China
2.Peking Univ, Clin Res Inst, Beijing 100871, Peoples R China
Recommended Citation
GB/T 7714
Jiang, Q.,Wang, H. B.,Mo, X. D.,et al. ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY[J]. HAEMATOLOGICA,2015,suppl.1:698-698.
APA Jiang, Q.,Wang, H. B.,Mo, X. D.,Yu, L.,&Huang, X. J..(2015).ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY.HAEMATOLOGICA,suppl.1,698-698.
MLA Jiang, Q.,et al."ACHIEVING EARLY OPTIMAL RESPONSE IS ASSOCIATED WITH BETTER HEALTH-RELATED QUALITY OF LIFE IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA TREATED WITH IMATINIB OR NILOTINIB AS FRONTLINE THERAPY".HAEMATOLOGICA suppl.1(2015):698-698.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
谷歌学术
谷歌学术Similar articles in
[Jiang, Q.]'s Articles
[Wang, H. B.]'s Articles
[Mo, X. D.]'s Articles
百度学术
百度学术Similar articles in
[Jiang, Q.]'s Articles
[Wang, H. B.]'s Articles
[Mo, X. D.]'s Articles
必应学术
必应学术Similar articles in
[Jiang, Q.]'s Articles
[Wang, H. B.]'s Articles
[Mo, X. D.]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.